159 related articles for article (PubMed ID: 27422136)
1. Evaluation of the point of care Afinion AS100 analyser in a community setting.
Jain A; Rao N; Sharifi M; Bhatt N; Patel P; Nirmal D; Persaud JW; Nair DR
Ann Clin Biochem; 2017 May; 54(3):331-341. PubMed ID: 27422136
[TBL] [Abstract][Full Text] [Related]
2. Good correlation between the Afinion AS100 analyser and the ABX Pentra 400 analyser for the measurement of glycosylated haemoglobin and lipid levels in older adults in Durban, South Africa.
Abbai NS; Nyirenda M; Reddy T; Ramjee G
S Afr Med J; 2017 Dec; 108(1):50-55. PubMed ID: 29262979
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus.
Torregrosa ME; Molina J; Argente CR; Ena J
Endocrinol Nutr; 2015 Dec; 62(10):478-84. PubMed ID: 26531840
[TBL] [Abstract][Full Text] [Related]
4. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
[TBL] [Abstract][Full Text] [Related]
5. Verification of point-of-care analysers for C-reactive protein, lipid studies and glycated haemoglobin.
Li B; Kumar A; Finlay C; van Drimmelen M; Barnes E; Southby S; Florkowski C
Pathology; 2023 Dec; 55(7):989-999. PubMed ID: 37778963
[TBL] [Abstract][Full Text] [Related]
6. Point of care testing is appropriate for National Health Service health check.
Jain A; Persaud JW; Rao N; Harvey D; Robertson L; Nirmal L; Nirmal D; Thomas M; Mikhailidis DP; Nair DR
Ann Clin Biochem; 2011 Mar; 48(Pt 2):159-65. PubMed ID: 21355015
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
Dale RA; Jensen LH; Krantz MJ
Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the performance of urine albumin, creatinine and albumin-creatinine ratio assay on two POCT analyzers relative to a central laboratory method.
Omoruyi FO; Mustafa GM; Okorodudu AO; Petersen JR
Clin Chim Acta; 2012 Mar; 413(5-6):625-9. PubMed ID: 22212624
[TBL] [Abstract][Full Text] [Related]
9. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
Whitehead SJ; Ford C; Gama R
Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of HbA1c analyzers: D-10, Variant II Turbo, Cobas Integra 800, and Afinion AS100].
Lee JY; Hong KS; Cho SE
Korean J Lab Med; 2010 Aug; 30(4):345-50. PubMed ID: 20805705
[TBL] [Abstract][Full Text] [Related]
11. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities.
Shemesh T; Rowley KG; Shephard M; Piers LS; O'Dea K
Clin Chim Acta; 2006 May; 367(1-2):69-76. PubMed ID: 16388790
[TBL] [Abstract][Full Text] [Related]
12. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care testing in diabetes care.
Matteucci E; Giampietro O
Mini Rev Med Chem; 2011 Feb; 11(2):178-84. PubMed ID: 21222582
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.
Saxton AT; Miranda JJ; Ortiz EJ; Pan W
Ann Glob Health; 2018 Nov; 84(4):618-624. PubMed ID: 30779508
[TBL] [Abstract][Full Text] [Related]
15. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control.
Reverter JL; Sentí M; Rubiés-Prat J; Lucas A; Salinas I; Pizarro E; Pedro-Botet J; Romero R; Sanmartí A
Diabetes Care; 1994 Mar; 17(3):189-94. PubMed ID: 8174446
[TBL] [Abstract][Full Text] [Related]
16. Results of an Aboriginal community-based renal disease management program incorporating point of care testing for urine albumin:creatinine ratio.
Shephard MD; Allen GG; Paizis K; Barbara JA; Batterham M; Vanajek A
Rural Remote Health; 2006; 6(4):591. PubMed ID: 17022724
[TBL] [Abstract][Full Text] [Related]
17. Comparative performance of two point-of-care analysers for lipid testing.
Shephard MD; Mazzachi BC; Shephard AK
Clin Lab; 2007; 53(9-12):561-6. PubMed ID: 18257461
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.
Wood JR; Kaminski BM; Kollman C; Beck RW; Hall CA; Yun JP; Cengiz E; Haller MJ; Hassan K; Klingensmith GJ; Tamborlane WV
J Diabetes Sci Technol; 2012 Mar; 6(2):380-6. PubMed ID: 22538150
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
